Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · Real-Time Price · USD
1.810
+0.030 (1.69%)
At close: Feb 20, 2026, 4:00 PM EST
1.807
-0.003 (-0.17%)
After-hours: Feb 20, 2026, 8:00 PM EST
Lineage Cell Therapeutics Employees
As of December 31, 2024, Lineage Cell Therapeutics had 77 total employees, including 70 full-time and 7 part-time employees. The number of employees increased by 2 or 2.67% compared to the previous year.
Employees
77
Change (1Y)
2
Growth (1Y)
2.67%
Revenue / Employee
$140,468
Profits / Employee
-$878,662
Market Cap
438.61M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 77 | 2 | 2.67% | 70 | 7 |
| Dec 31, 2023 | 75 | -3 | -3.85% | 68 | 7 |
| Dec 31, 2022 | 78 | 17 | 27.87% | 70 | 8 |
| Dec 31, 2021 | 61 | 6 | 10.91% | 57 | 4 |
| Dec 31, 2020 | 55 | 0 | - | 49 | 6 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 650 |
| Lyell Immunopharma | 300 |
| Kyverna Therapeutics | 129 |
| Invivyd | 100 |
| Solid Biosciences | 100 |
| Assembly Biosciences | 73 |
| PepGen | 57 |
| DiaMedica Therapeutics | 28 |
LCTX News
- 6 weeks ago - Lineage Takes Delivery of Gene-edited Hypoimmune Cell Line Under Partnership With Factor Bioscience - Business Wire
- 6 weeks ago - Lineage Cell Therapeutics Issues Letter to Stockholders - Business Wire
- 3 months ago - Lineage Cell Therapeutics: OpRegen Makes It A Viable Speculative Buy - Seeking Alpha
- 3 months ago - Lineage Cell Therapeutics, Inc. (LCTX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Lineage Cell Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update - Business Wire
- 4 months ago - Lineage Cell Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025 - Business Wire
- 5 months ago - Lineage Cell Therapeutics, Inc. (LCTX) Presents At H.C. Wainwright 27th Annual Global Investment Conference Prepared Remarks Transcript - Seeking Alpha
- 5 months ago - Lineage Cell Therapeutics Initiates Cell Transplant Program In Type 1 Diabetes - Business Wire